{
  "experiment": "Exp 14: Mutation \u2192 SL \u2192 Drug Mapping",
  "total_patients": 1577,
  "total_mutations": 37063,
  "cancer_types": [
    "BRCA",
    "LUAD",
    "KIRC"
  ],
  "sl_targetable_patients": 965,
  "druggable_patients": 210,
  "unique_sl_targets": 124,
  "unique_drivers": 14,
  "top_recommendations": [
    {
      "driver_mutation": "STK11",
      "sl_target": "CCND1",
      "patient_id": 72,
      "approved_drugs": "ACETAMINOPHEN, SELADELPAR, TROGLITAZONE"
    },
    {
      "driver_mutation": "BRCA2",
      "sl_target": "TP53",
      "patient_id": 65,
      "approved_drugs": "VEMURAFENIB, PACLITAXEL, ERLOTINIB"
    },
    {
      "driver_mutation": "BRCA1",
      "sl_target": "MYC",
      "patient_id": 51,
      "approved_drugs": "DIETHYLSTILBESTROL, METHYLPREDNISOLONE, OLAPARIB"
    },
    {
      "driver_mutation": "BRCA1",
      "sl_target": "CDK6",
      "patient_id": 51,
      "approved_drugs": "PALBOCICLIB, ABEMACICLIB, TRILACICLIB DIHYDROCHLORIDE"
    },
    {
      "driver_mutation": "BRAF",
      "sl_target": "TP53",
      "patient_id": 46,
      "approved_drugs": "VEMURAFENIB, PACLITAXEL, ERLOTINIB"
    }
  ]
}